SEC Info - AnPac Bio-Medical Science Co., Ltd.

SEC Info℠

Home

Help

Please Sign In

AnPac Bio-Medical Science Co., Ltd. – ‘6-K’ for 9/27/22

On: Tuesday, 9/27/22, at 6:03am ET · For: 9/27/22 · Accession #: 1104659-22-103112 · File #: 1-39137

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/27/22  AnPac Bio-Medical Science Co, Ltd 6-K         9/27/22    2:27K                                    Toppan Merrill/FA

Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K — SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current, Quarterly or Annual Report by a Foreign    HTML     10K 
                Issuer                                                           
 2: EX-99.1     Miscellaneous Exhibit                               HTML     12K

‘6-K’ — Current, Quarterly or Annual Report by a Foreign Issuer

This is an HTML Document rendered as filed. [ Alternative Formats ]

U.S. SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2022

Commission File Number: 001-39137

AnPac Bio-Medical Science Co., Ltd.

801 Bixing Street, Bihu County

Lishui, Zhejiang Province 323006

The People’s Republic of China

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x

Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

EXHIBIT INDEX

Exhibit		Description
99.1		Press release dated September 26, 2022

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

AnPac Bio-Medical Science Co., Ltd.

By:	/s/ *Dr. Chris Chang Yu*
	Name:	Dr. Chris Chang Yu
	Title:	Co-Chairman of the Board of Directors and Co-Chief Executive Officer

Dated: September 27, 2022

Dates Referenced Herein

This ‘6-K’ Filing	Date	Other Filings

Filed on / For Period end:	9/27/22	None on these Dates
		List all Filings

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/04/23  Fresh2 Group Ltd.                 424B5                  1:885K                                   EdgarAgents LLC/FA

↑Top

Filing Submission 0001104659-22-103112 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)